Crossref
APPLICATION OF GENETICALLY ENGINEERED TUMOR-SPECIFIC TH1 CELLS TO ADOPTIVE TUMOR IMMUNOTHERAPY
Annals of Cancer Research and Therapy · 2004
DOI: 10.4993/acrt.12.71 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Cancer Research and Therapy, 2004. Verfasst von Takemasa Tsuji und 4 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tsuji, T., Chamoto, K., Gyobu, H., Ikeda, H., & Nishimura, T. (2004). APPLICATION OF GENETICALLY ENGINEERED TUMOR-SPECIFIC TH1 CELLS TO ADOPTIVE TUMOR IMMUNOTHERAPY. Annals of Cancer Research and Therapy. https://doi.org/10.4993/acrt.12.71
Vancouver
Tsuji T, Chamoto K, Gyobu H, Ikeda H, Nishimura T. APPLICATION OF GENETICALLY ENGINEERED TUMOR-SPECIFIC TH1 CELLS TO ADOPTIVE TUMOR IMMUNOTHERAPY. Annals of Cancer Research and Therapy. 2004. doi:10.4993/acrt.12.71
BibTeX
@article{Tsuji2004,
author = {Tsuji, Takemasa and Chamoto, Kenji and Gyobu, Hiroshi and Ikeda, Hiroaki and Nishimura, Takashi},
title = {APPLICATION OF GENETICALLY ENGINEERED TUMOR-SPECIFIC TH1 CELLS TO ADOPTIVE TUMOR IMMUNOTHERAPY},
journal = {Annals of Cancer Research and Therapy},
year = {2004},
doi = {10.4993/acrt.12.71}
}
EUVIMED